Fierce Pharma
DECEMBER 18, 2024
Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. | Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were catalogued in a recent edition of the FDA's weekly enforcement report.
MedCity News
DECEMBER 18, 2024
SiteOne Therapeutics develops drugs that target sodium channels, the wiring in the body that transmits pain signals. Because SiteOnes targets are located in the peripheral nervous system, they should not pose the same addiction risks as opioids, which hit receptors in the central nervous system. The post Startup SiteOne Secures $100M to Forge Ahead With Novel Non-Opioid Pain Meds appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 18, 2024
Looking to significantly bolster its presence across Asia, Indian solid dosage manufacturer ACG has kicked off operations at a massive plant in Thailand. | ACG this week commenced work at its new, 175,000-square-meter capsule production plant in Rayong on Thailands east coast. The sprawling facility, which is bigger than 32 football fields, represents the largest of its kind in the country and is expected to crank out some 20 billion hard gelatin capsules per year.
pharmaphorum
DECEMBER 18, 2024
The FDA has started a review of MSD's RSV antibody clesrovimab, a potential rival to Beyfortus, with a verdict due in the middle of next year
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
DECEMBER 18, 2024
Like any other tool, understanding the right problem to apply it to is the difference between success and failure. Addressing a problem is never just about technology; its always about people, processes, and technology. The post The AI Advantage: Reimagining the Future of Drug Development appeared first on MedCity News.
pharmaphorum
DECEMBER 18, 2024
SiteOne Therapeutics has completed a $100 million third-round financing that will support clinical trials of its non-opioid painkiller.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Technology
DECEMBER 18, 2024
Abera and Orexo have entered a partnership to develop and test the powder formulations of the formers vaccine candidates.
MedCity News
DECEMBER 18, 2024
Wisp patients enrolled in its weight care program can now access nutrition counseling services with Nourish. The post Wisp Teams Up with Nourish to Combine GLP-1s with Nutrition Counseling appeared first on MedCity News.
Pharmaceutical Technology
DECEMBER 18, 2024
New hope for long-COVID patients: Longidaza boosts exercise tolerance and improves pulmonary function.
MedCity News
DECEMBER 18, 2024
Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market. The post Future Trends for Clinical Trials in 2025 and Beyond appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
DECEMBER 18, 2024
Industrial refrigeration is key to the healthcare industry, but it contributes massively to its emissions.
pharmaphorum
DECEMBER 18, 2024
Sensorion's gene therapy for otoferlin-related hearing loss has shown early signs of improving hearing in two toddlers in a phase 1/2 trial.
Pharmaceutical Technology
DECEMBER 18, 2024
A new report identifies data content management as the primary driver of growth in the pharmaceuticals market.
pharmaphorum
DECEMBER 18, 2024
Luigi Mangione has been charged with first-degree murder "in furtherance of terrorism" in connection with the death of the UnitedHealth CEO
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Technology
DECEMBER 18, 2024
Gilead Sciences has entered a strategic partnership with Terray for the discovery and development of small-molecule therapies.
MedCity News
DECEMBER 18, 2024
Congress released a stopgap funding bill with a significant healthcare package, and provider groups are reacting favorably. They are mainly applauding provisions that reign in PBMs business practices, extend telehealth flexibilities, and boost payments to hospitals and physicians. The post How Did Provider Groups React to Congress End-of-Year Healthcare Package?
Pharmaceutical Technology
DECEMBER 18, 2024
Improper advertising on media constituted a large part of traffic directed to the companies websites.
Pharmaceutical Commerce
DECEMBER 18, 2024
Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses observations in enterprise value growth and enterprise value-to-sales ratios among top biopharmaceutical companies.
Pharmaceutical Technology
DECEMBER 18, 2024
Picking the right clinical partners will be critical for oncology innovators hoping to stay up to speed in a rapidly changing industry.
PharmExec
DECEMBER 18, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
DECEMBER 18, 2024
Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection.
PharmExec
DECEMBER 18, 2024
Breakthrough Therapy designation for Trodelvy was granted based on promising results from the Phase II TROPiCS-03 study, which showed encouraging antitumor activity in both platinum-resistant and platinum-sensitive extensive-stage small cell lung cancer.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
pharmaphorum
DECEMBER 18, 2024
Tune in to the podcast interview with Luca Quagliata from Thermo Fisher Scientific as he discusses the quantum leap in biomarkers and precision medicine in the age of Next-Generation Sequencing (NGS).
PharmExec
DECEMBER 18, 2024
Complementing our own industry trends and outlook coverage this month are a trio of diverse crystal-ball perspectives from guest thought leaders.
Pharmaceutical Commerce
DECEMBER 18, 2024
Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.
PharmExec
DECEMBER 18, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmaVoice
DECEMBER 18, 2024
The pharma giant is looking for another edge in the competitive weight loss market through DTC expansion.
PharmExec
DECEMBER 18, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
European Pharmaceutical Review
DECEMBER 18, 2024
The first randomised, placebo-controlled study to evaluate the impact of an anti-TL1A monoclonal antibody (mAb) in Crohns disease has demonstrated for high dose the highest achieved primary endpoint results in ulcerative colitis and Crohns with any TL1A mAb.The Phase IIb RELIEVE UCCD study evaluated the human IgG1-2 monoclonal antibody duvakitug (TEV574/SAR447189), which targets TL1A.
PharmaTech
DECEMBER 18, 2024
AbbVie's latest acquisition target is Nimble Therapeutics, which will give AbbVie a lead asset, an oral peptide for treating psoriasis.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
150 
Let's personalize your content